Wesbanco Bank Inc. Sells 4,707 Shares of CVS Health Corporation $CVS

15 Sep 2025, 06:32 by Doug Wharley · The Cerbat Gem

Wesbanco Bank Inc. lessened its stake in CVS Health Corporation (NYSE:CVS – Free Report) by 10.0% during the second quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 42,352 shares of the pharmacy operator’s stock after selling 4,707 shares during the quarter. Wesbanco Bank Inc.’s holdings in CVS Health were worth $2,921,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also bought and sold shares of CVS. Jennison Associates LLC increased its holdings in shares of CVS Health by 503.8% in the first quarter. Jennison Associates LLC now owns 1,896,341 shares of the pharmacy operator’s stock worth $128,477,000 after purchasing an additional 1,582,257 shares during the period. Cerity Partners LLC boosted its position in CVS Health by 25.0% during the first quarter. Cerity Partners LLC now owns 648,266 shares of the pharmacy operator’s stock valued at $43,920,000 after buying an additional 129,535 shares during the period. Bank of New York Mellon Corp boosted its position in CVS Health by 2.1% during the first quarter. Bank of New York Mellon Corp now owns 8,981,262 shares of the pharmacy operator’s stock valued at $608,481,000 after buying an additional 183,813 shares during the period. Brandywine Global Investment Management LLC boosted its position in CVS Health by 20.1% during the first quarter. Brandywine Global Investment Management LLC now owns 3,421,519 shares of the pharmacy operator’s stock valued at $231,808,000 after buying an additional 572,533 shares during the period. Finally, Skandinaviska Enskilda Banken AB publ boosted its holdings in shares of CVS Health by 122.5% during the first quarter. Skandinaviska Enskilda Banken AB publ now owns 565,152 shares of the pharmacy operator’s stock worth $38,289,000 after purchasing an additional 311,098 shares during the period. Institutional investors own 80.66% of the company’s stock.

Analyst Ratings Changes

Several analysts have commented on the stock. Cantor Fitzgerald restated an “overweight” rating and issued a $78.00 price objective on shares of CVS Health in a report on Tuesday, August 26th. Jefferies Financial Group raised their price target on shares of CVS Health from $74.00 to $80.00 and gave the company a “buy” rating in a research report on Monday, June 30th. Morgan Stanley raised their price target on shares of CVS Health from $80.00 to $82.00 and gave the company an “overweight” rating in a research report on Friday, August 1st. Barclays raised their price target on shares of CVS Health from $80.00 to $87.00 and gave the company an “overweight” rating in a research report on Thursday, September 4th. Finally, Zacks Research cut shares of CVS Health from a “strong-buy” rating to a “hold” rating in a report on Monday, September 8th. Two investment analysts have rated the stock with a Strong Buy rating, nineteen have issued a Buy rating and three have assigned a Hold rating to the company’s stock. According to data from MarketBeat, CVS Health currently has an average rating of “Moderate Buy” and a consensus target price of $77.89.

Get Our Latest Analysis on CVS

CVS Health Stock Up 0.4%

CVS opened at $75.00 on Monday. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.62 and a current ratio of 0.80. CVS Health Corporation has a fifty-two week low of $43.56 and a fifty-two week high of $75.55. The firm’s fifty day moving average is $67.11 and its 200 day moving average is $66.33. The stock has a market cap of $95.12 billion, a price-to-earnings ratio of 20.95, a price-to-earnings-growth ratio of 0.83 and a beta of 0.62.

CVS Health (NYSE:CVS – Get Free Report) last announced its quarterly earnings results on Thursday, July 31st. The pharmacy operator reported $1.81 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.46 by $0.35. The company had revenue of $98.92 billion for the quarter, compared to the consensus estimate of $94.87 billion. CVS Health had a net margin of 1.17% and a return on equity of 10.51%. CVS Health’s revenue for the quarter was up 8.4% compared to the same quarter last year. During the same period in the previous year, the firm posted $1.83 EPS. CVS Health has set its FY 2025 guidance at 6.300-6.400 EPS. On average, sell-side analysts forecast that CVS Health Corporation will post 5.89 earnings per share for the current fiscal year.

CVS Health Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Friday, August 1st. Stockholders of record on Tuesday, July 22nd were issued a $0.665 dividend. The ex-dividend date was Tuesday, July 22nd. This represents a $2.66 dividend on an annualized basis and a dividend yield of 3.5%. CVS Health’s payout ratio is 74.30%.

Insider Activity at CVS Health

In related news, Director Anne A. Finucane sold 7,500 shares of CVS Health stock in a transaction dated Wednesday, August 20th. The shares were sold at an average price of $71.02, for a total transaction of $532,650.00. Following the completion of the transaction, the director directly owned 22,156 shares of the company’s stock, valued at approximately $1,573,519.12. The trade was a 25.29% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Corporate insiders own 1.22% of the company’s stock.

CVS Health Profile

(Free Report)